BY OUR PLATFORMS
BY THERAPEUTIC AREA
BY RESEARCH STAGE
26 June 2019 - 28 June 2019
For many years ZeClinics bet to enter the Japanese market, and we made visits over the years, receiving very good feedbacks and completing the first trials. Far is that first day, but even having consolidated our presence in this wonderful country, we continue going twice a year.
This time our BD Manager, Jana Iscla Bosch, is enjoying the #JSOT2019 in Tokushima. And do not forget our Luncheon Seminar 10 ランチョンセミナー 10 titled "ZeTox: the platform for predicting toxicity and endocrine disruptors through zebrafish screenings". And meet us at booth 34 of the Exhibition Hall.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.